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Abstract
Background & Aim—Inflammatory arthropathies are common extraintestinal manifestations of
inflammatory bowel diseases (IBD). As genetic susceptibility plays an important role in the
etiology of IBD, we questioned how granulomatous enterocolitis and arthritis are genetically
controlled in an experimental animal model displaying both conditions.
Methods—Chronic intestinal and systemic inflammation was induced by intramural injection of
peptidoglycan-polysaccharide (PG-PS) polymers in the ileocaecal region of female F2 progeny
derived from susceptible LEW and resistant F344 rats. Animals were followed for 24 days after
injection and phenotyped by evaluating gross gut lesions, liver weight and granulomas,
hematocrit, white blood cell count, and change in rear ankle joint diameters. Coinheritance of the
phenotypic parameters with polymorphic DNA markers was analyzed by genome-wide
quantitative trait locus (QTL) analysis.
Results—Linkage analysis revealed significant QTLs for enterocolitis and/or related phenotypes
(liver granulomas, white blood cell count) on chromosomes 8 and 17. The QTL on chromosome 8
also showed suggestive linkage to arthritis. Significant QTLs for arthritis were detected on
chromosomes 10, 13, 15, and 17. Analyses of the modes of inheritance showed arthritogenic
contributions by both parental genomes. In addition, several other loci with suggestive evidence
for linkage to one or several phenotypes were found.
Conclusion—Susceptibility to PG-PS-induced chronic intestinal and systemic inflammation in
rats is under complex multigenic control in which the genetic loci regulating arthritis are largely
different from those controlling enterocolitis. Possible candidate genes within these QTL
(including Tnfrsf11a/RANK, Gpc5, Il2ra, and Nfrkb) are also implicated in the respective human
diseases.
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Introduction
Inflammatory bowel diseases (IBD) in humans encompass a heterogeneous collection of
chronic inflammatory conditions, including Crohn´s disease (CD) and ulcerative colitis
(UC). Both CD and UC are not restricted to the gastrointestinal tract and often involve other
organs such as joints, skin, liver, and eyes. Up to 47% of the patients with IBD have
extraintestinal manifestations, 1 among which inflammatory arthropathies (such as
peripheral arthritis, ankylosing spondylitis, and sacroiliitis) are most common with a
prevalence ranging between 7% and 25%.2,3
Although progress was made in identifiying predisposing genetic factors such as
polymorphisms in the NOD2/CARD15 gene,4,5 development of IBD entails complex and as
yet poorly understood interactions between host genetics and environmental influences.6 A
valuable experimental model of IBD for the analysis of host genetic factors is the
peptidoglycan-polysaccharide (PG-PS)-induced rat model of chronic intestinal and systemic
inflammation. In this model, injection of PG-PS polymers derived from group A
streptococci into the intestinal wall of genetically susceptible rats induces acute
inflammation at the injection site followed by a spontaneously reactivating granulomatous
enterocolitis and systemic inflammation similar to extraintestinal manifestations of IBD.7–9
This susceptibility to spontaneous reactivation is restricted to Lewis (LEW) and Sprague-
Dawley rats and does not appear in Fischer 344 (F344) and Buffalo rats. Female LEW rats,
the highest responders, develop acute intestinal inflammation that peaks 1–2 days after PG-
PS injection, gradually decreases over the next 10 days, and spontaneously reactivates
beginning on day 14 to produce a chronic, granulomatous fibrotic transmural inflammation
that is T cell-mediated and accompanied by extraintestinal manifestations of erosive
arthritis, granulomatous hepatitis, normochromic anemia, and leukocytosis that persists for
at least 16 weeks.
The aim of this study was to identify chromosomal locations that determine genetic
susceptibility to chronic enterocolitis and systemic inflammation in PG-PS-treated female
rats of an F2 population segregating for LEW and F344 alleles by quantitative trait locus
(QTL) analysis. Both strains express the same haplotypes of major histocompatibility
complex (MHC) genes involved in antigen presentation (MHC class Ia and class II),10




Susceptible specific pathogen free (SPF) LEW rats (females) and resistant F344 rats (males)
obtained from Charles River (Raleigh, North Carolina) were crossed and F1 hybrids
intercrossed to produce 168 female (LEW×F344)F2 segregants under SPF conditions at the
University of North Carolina at Chapel Hill.
All rat experiments were conducted in accordance with the standards of the National
Institutes of Health’s Guide for the Care and Use of Laboratory Animals and approved by
the University of North Carolina Institutional Animal Care and Use Committee.
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Induction of enterocolitis and systemic inflammation
PG-PS was prepared from group A, type 3, strain D58 streptococci (Streptococcus
pyogenes) as previously described;9,11 several sonicates were pooled so that all rats
obtained the same homogenous preparation. Female F2 rats (150–160 g body weight) were
anesthetized with 80 mg/kg body weight ketamine and 0.15 mg/kg acepromazine maleate
intramuscularly. Their intestines were exposed by laparotomy using aseptic technique and
0.05 ml PG-PS suspension (45 mg/kg dry weight [15 mg rhamnose/kg]) was injected
intramurally into 7 sites (two Peyer’s patches in the distal ileum, two locations at the
junction between the mesentery and terminal ileum, and three locations in the cecum
including the lymphoid aggregate at the cecal tip). The abdominal cavity was closed and rats
were allowed free access to food and water. Rats were followed for 24 days after treatment
to allow full development of the chronic phase of inflammation and subsequently euthanized
by CO2-inhalation and exsanguination.
Phenotyping
Arthritis—Joint diameters (in millimeters) of the rear ankles were measured on day 0, 17,
21, and 24 of treatment and differences to pre-injection values calculated. Furthermore,
differences in diameter of both ankles at day 24 compared to values before treatment were
summed up.
Gross gut score—At necropsy, enterocolitis was assessed based on a validated 0–4
grading system by determining cecal granulomas, cecal wall thickening, mesenteric
contraction and adhesions, resulting in a maximal score of 16.7,9
In addition, livers were weighed (mg liver/g body weight) and granulomas in the livers
assessed using a 0–4 scoring system. Cardiac blood samples were analyzed for hematocrit
(%) and white blood cell count (103/mm3).
Genotyping
Genomic DNA was isolated from frozen auricular or kidney tissues using the QIAamp DNA
Mini Kit (Qiagen, Hilden, Germany) following the manufacturer’s protocol. DNAs were
genotyped by PCR amplification of 130 microsatellite markers polymorphic between LEW
and F344 strains (D1Rat186, D1Rat313, D1Rat268, D1Rat350, D1Rat66, D1Rat70,
D1Rat169, D1Rat90, D2Rat201, D2Mit6, D2Rat135, D2Rat26, D2Rat147, D2Rat236,
D2Rat62, D2Rat69, D2Rat342, D2Rat167, D2Rat41, D2Rat99, D3Rat82, D3Rat108,
D3Rat166, D3Rat5, D3Rat3, D4Rat2, D4Rat153, D4Rat48, D4Rat137, D4Mit24,
D4Rat112, D5Rat126, D5Rat82, D5Mit10, D5Rat85, D5Rat30, D5Rat93, D5Rat49,
D6Rat68, D6Rat135, D6Rat165, D6Rat160, D7Rat63, D7Rat113, D7Rat107, D7Rat24,
D7Rat99, D7Rat4, D7Mgh9, D7Rat26, D7Rat44, D7Mgh3, D7Rat81, D7Rat153, D7Rat150,
D8Rat77, D8Arb6, D8Rat156, D8Rat129, D8Rat119, D8Rat105, D8Rat164, D8Rat99,
D8Rat159, D8Rat16, D9Rat162, D9Rat41, D9Rat19, D9Rat4, D9Rat1, D10Rat218,
D10Rat46, D10Rat45, D10Rat164, D10Rat26, D10Rat142, D10Rat15, D10Rat108,
D10Rat37, D10Rat32, D10Rat98, D10Rat155, D10Mgh5, D11Rat11, D11Rat6, D11Arb4,
D11Rat56, Kng, D12Rat4, D12Mit4, D12Rat20, D13Rat113, D13Rat26, D13Rat131,
D13Rat7, D13Rat120, D13Arb8, D14Rat78, D14Rat77, D14Rat15, D14Rat18, D14Rat49,
D15Rat66, D15Rat123, D15Mgh8, D15Rat106, D15 Rat155, D16Rat102, D16Rat53,
D16Rat15, D17Rat8, D17Rat151, D17Rat65, D17Rat11, D17Rat15, D17Mgh5, D17Rat89,
D17Rat62, D18Rat17, D18Rat61, D18Rat5, D19Rat82, D19Rat12, D19Rat64, D20Rat46,
D20Rat34, D20Arb10, DXRat82, DXRat43, DXRat104). Marker positions were taken from
the Rat Genome Database (www.rgd.mcw.edu), primer sequences from The Jackson
Laboratory's online Mouse Genome Informatics resource (www.informatics.jax.org).
Bleich et al. Page 3













PCR reaction volume was 12 µl which contained 50 ng DNA, 0.14 µM of each primer
(Roth, Karlsruhe, Germany), 12.5 mM Tris-HCl (pH 8.3), 62.5 mM KCl, 2.5 mM MgCl2,
0.52 mM of each dNTP, 3× MasterAmp™ PCR enhancer, and 0.5 U of Amplitherm™ DNA
polymerase (Epicentre Technologies, Madison, WI). Thirty-five PCR cycles, consisting of
15 sec at 94 °C, 1 min at 55 °C, and 2 min at 72 °C, preceded by an initial denaturation step
of 4 min at 95 °C and followed by a final extension step of 7 min at 72 °C, were performed
in 96-well microtiter plates using a PTC-200 thermal cycler (MJ Research, Watertown,
MA). For some markers, modifications of the protocol, primarily of the MgCl2
concentration, were performed to optimize reactions. PCR products were analyzed by
electrophoresis on 3% (w/v) NuSieve™ agarose gels (Bioproducts, Rockland, ME)
containing GelStar (Biozym, Hess. Oldendorf, Germany) and visualized under UV light.
Statistical and QTL analyses
Spearman rank correlation analysis was used to determine the relationship between the traits
under study. In addition, data were analyzed by factor analysis using a principal components
solution with orthogonal rotation (varimax) of the factor matrix. This method ensures that
the extracted factors are independent of one another and should, therefore, reflect separate
processes. The varimax algorithm was chosen because this algorithm attempts to minimize
the number of variables that have high loadings (see hereafter) on a factor. This approach
should enhance the interpretability of the factors. The sampling adequacy was measured
with the Kaiser-Meyer-Olkin measure (should be greater than 0.5). The Bartlett’s test of
sphericity was used for testing whether the correlation was appropriate for factor analysis.
Factor pattern matrices were identified using a combination of the Kaiser criterion (factor
must have eigenvalues ≥ 1) and the Scree test (on a simple line plot, the point of inflection
of a plot of the eigenvalues from largest to smallest). The factor loading of each item
indicates how well this item correlates with the factor; thus a loading of ±1.0 indicates a
perfect (positive/negative) correlation, whereas a loading of less then 0.6 would suggest that
the item is rather weakly linked to the factor. Statistical significance was defined as p ≤
0.05.
The location of the QTLs affecting the traits was determined by using the MapQTL
computer package 12. Both the interval mapping module (for normally distributed
transformed enterocolitis-related and arthritis-related phenotypes)13 and the non-parametric
mapping module (only for enterocolitis-related phenotypes)14 were used. The Kolmogorov-
Smirnov one-sample test was used to check normality of the traits. The non-normally
distributed traits were transformed to a normal distribution15 using the following
transformations: i) logarithmic (y =10Log[x + a]), ii) logistic (y = [x + a]/[b − x]) or iii)
inverse function (y = 1/[x + a]); where y is the transformed trait value, x is the original trait
value and a and b are constants. Application of the interval mapping module on the
transformed traits is then straightforward.
Results were expressed as Lod scores for normally distributed traits and Kruskal-Wallis test
statistics for non-normally distributed traits. Lod score thresholds to achieve the genome-
wide significance levels of 5% (significant linkage) were, as proposed by Lander and
Kruglyak,16 4.3 when no model of gene action was specified ("free" genetics), 3.4 when
gene action was restricted to recessive or dominant models, and 3.3 when gene action was
restricted to an additive model. For suggestive linkage, Lod score values were 2.8 ("free"
genetics), 2.0 (recessive or dominant) and 1.9 (additive), respectively. For the non-
parameteric approach p ≤ 0.01 and p ≤ 0.005 were considered to indicate suggestive and
significant linkage, respectively. Whenever a QTL was found or suggested using the
MapQTL software, Student's t tests (normally traits) or Median test (non-normally
distributed traits) were performed for the markers flanking the peak of the QTL or at the
peak of the QTL. In case of interval mapping, the mode of inheritance was chosen as free,
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additive, dominant or recessive according to the significance of differences in the mean
values of the traits between rats that were homozygous LEW, heterozygous LEW:F344 and
homozygous F344.
Results
Correlations and factor analysis
Positive correlations were seen between each of the following traits: gross gut score
(enterocolitis), liver weight, liver granulomas, and white blood cell count, with Spearman
correlation coefficients (rs) ranging between 0.76 and 0.85 (p < 0.0001). Negative
correlations were observed between all traits mentioned above and hematocrit (rs = −0.57 to
−0.77; p < 0.0001). Because of these high correlations, these traits were designated
“enterocolitis-related phenotypes”. No correlation was observed between enterocolitis-
related and arthritis-related (i.e. increase in joint diameter) phenotypes, except for a weak
correlation between gross gut score and sum of increase in joint diameter of the right and
left rear ankle on day 24 (rs = 0.16; p = 0,0389).
The factor analysis included the following parameters: gross gut score, liver weight, liver
granulomas, white blood cell count, hematocrit and the increase in joint diameters (days 17,
21 and 24; left and right rear ankle). A specific assumption for a factor analysis is that the
parameter should not be fully derived from one or more of the other included parameters.
Therefore, sum of increase in joint diameter of left and right rear ankles (on day 24) was not
included. Two clear factors emerged accounting for 77.1% of the total variance (Table 1).
Factor 1 explained 48.3% of the total variance and appeared to reflect enterocolitis, whereas
factor 2 explained 28.8% and reflected arthritis.
QTL analyses
All traits were non-normally distributed in the F2 population (not shown); therefore,
transformation to a normal distribution was applied for interval mapping (Table 2).
Enterocolitis-related phenotypes
Significant and suggestive QTLs for enterocolitis-related phenotypes calculated by interval
mapping and Kruskal-Wallis tests are shown in Table 3. Significant QTLs were detected on
chromosome (chr.) 8 and 17, all derived from the LEW strain. On chr. 8, a significant
contribution was seen for a locus around 26–29 cM to gross gut score (as determined by
interval mapping and Kruskal-Wallis test), liver granulomas, and white blood cell count
(both determined by Kruskal-Wallis tests) in a recessive manner, as well as a suggestive
contribution to liver weight and hematocrit. On chr. 17, a significant QTL for liver
granulomas was located at 69 cM (Kruskal-Wallis test). Furthermore, suggestive QTLs were
detected on chr. 1 for hematocrit and on chr. 5 and 7 for white blood cell count. Taken
together, the chr. 8 locus, explaining 10.2% of the genetic variance of the gross gut score
and 9.0% of the genetic variance of liver granulomas and white blood cell count, has the
most important effect on enterocolitis-related phenotypes, followed by a QTL on chr. 17 that
explains 8.4% of the genetic variation of liver granulomas.
Arthritis-related phenotypes
Significant and suggestive arthritogenic QTLs are shown in Table 4 and Table 5. Significant
QTLs were detected on chr. 10, 13, and 15 (with arthritogenic contributions from the LEW
genome), and on chr. 17 (with an arthritogenic contribution from the F344 genome). A locus
with a peak Lod score at 69.0 cM on chr. 10 was associated with an increase in joint
diameter of the right ankle on days 17 and 21 in a recessive manner, and a locus with a peak
at 76 cM was associated with an increase in diameter of the left ankle on day 21 as well as
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the summed increase of the left and right ankle on day 24 in a dominant fashion. The LEW
allele of this QTL explained up to 18.4% of the genetic variance, showing a major
contribution of this QTL to arthritis susceptibility. In addition, a QTL for arthritis of the left
ankle on day 24 peaked at 70 cM and showed a dominant mode of inheritance. The presence
of multiple peaks on chr. 10 indicates that several genetic factors on this chromosome may
contribute to arthritis susceptibility (Fig. 1). Proximal chr. 13 (peak Lod scores between 2.0
and 7.0 cM) contributed to arthritis susceptibility in a dominant fashion and explained up to
12.8 % of the genetic variance of arthritis-related traits. A QTL at 87.0 cM on chr. 15
showed significant linkage and a second locus at 55.0 cM suggestive linkage to arthritis of
the left ankle on day 17. The first was inherited in a recessive, the second in a dominant
manner. A QTL on chr. 17 was significantly associated to arthritis of the left ankle on day
17, 21, and 24 as well as the summed up increase in joint diameter on day 24 and peaked
between 51.0 and 52 cM. Suggestive linkage was identified for the same locus to increases
of joint diameters of the right ankle on all three days. Additional suggestive linkage to
arthritis-related phenotypes was detected on chr. 2, 7, 8, and 20 (Table 5).
Discussion
Inflammatory arthropathies are common extraintestinal manifestations of IBD. As genetic
susceptibility plays an important role in the etiology of IBD, we questioned how chronic
granulomatous enterocolitis and arthritis are genetically controlled in an experimental model
displaying both conditions, the PG-PS-induced rat model of chronic intestinal and systemic
inflammation. In this model, PG-PS is injected intramurally into different locations of the
gut. As the response to these bacterial polymers is different between LEW (susceptible) and
F344 (resistant) rats, these two inbred strains were chosen to breed a segregating F2
population that was used for QTL analysis. In addition, both strains express the same
haplotypes of major histocompatibility complex (MHC) genes involved in antigen
presentation (MHC class Ia and class II) 10, which facilitates the analysis of non-MHC
determinants of inflammatory susceptibility. In humans, the MHC locus accounts for
approximately 50% of familial aggregation of rheumatoid arthritis together with PTPN22.17
The Ptpn22 gene is located on rat chr. 2 but not within the region containing the suggestive
QTL identified in this study.
Linkage analysis revealed that susceptibility to enterocolitis and arthritis is under complex
multigenic control. Interestingly, QTLs determining susceptibility to arthritis were largely
different from those controlling enterocolitis and correlated phenotypes (liver weight and
granulomas, anemia, leukocytosis). It should be noted that some QTLs may have been
missed or had less significance in our study because only gross phenotypic measures,
specifically measurement of joint diameters and gross gut score (and no histology), were
taken. This is corroborated by a recent study which shows that detailed histologic
phenotyping enhances power to detect colitis QTLs in mice.18 Our results indicate that
genetic factors that modulate enterocolitis are localized on chr. 8 (with peak linkage at 26–
29 cM) and 17 (peak linkage 69 cM), whereas factors that contribute to arthritis
susceptibility are localized on chr. 10 (69–76 cM), 13 (4–7 cM), 15 (87 cM), and 17 (51–52
cM). If suggestive QTLs are taken into account, the QTL on chr. 8 might also determine
susceptibility to arthritis. The suggestive enterocolitis- and arthritis-associated QTLs on chr.
7 are probably not in linkage (3 cM vs 48–69 cM) pointing to distinct QTLs on this
chromosome. The suggestive enterocolitis-related QTL affecting white blood cell count on
chr. 5 maps within a locus that is known as a modifier of white blood cell count (Wbc1)
detected previously in a QTL analysis dissecting cardiovascular phenotypes of hypertension
19. This locus also overlaps with a QTL for anti-collagen antibody titer (Ciaa5) in the
collagen-induced arthritis model.20
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As the chr. 8 QTL shows association to both enterocolitis and arthritis phenotypes, the
underlying gene likely plays a general role in inflammatory mechanisms. The peak of the
QTL on chr. 8 maps proximal to an unnamed QTL with suggestive linkage to collagen-
induced arthritis, Cia6, and Pia14;21 the human orthologous region contains RA19.22 An
obvious candidate gene within the peak linkage is Nfrkb (nuclear factor related to kappa B).
The role of Nfkb in IBD has been well described and a genetic association with intestinal
inflammation has been demonstrated in human ulcerative colitis23 and has been implicated
in experimental colitis in mice.24 Nfrkb is upregulated in inflammatory processes and has
been originally identified to bind to a related variant of the kappa B site that regulates
interleukin-2 receptor alpha-chain (Il2ra) gene expression, a critical event in T-cell
activation.25 The rat Il2ra gene is located on chr. 17 within a region that showed association
with colitis and arthritis phenotypes in our study. These loci are spaced approximately 15
cM apart. Therefore, it remains to be determined if a common QTL controls susceptibility to
both diseases. In humans, variants around the IL2RA gene showed disease association in a
linkage study that combined rheumatoid arthritis and type 1 diabetes 17, and the linkage to
arthritis was replicated in a subsequent meta-analysis.26 The proximal part of the QTL
interval also overlaps with a region that maps to chr. 1 in humans and contains the QTL
RA2.27 The IL-2 receptor (CD25) is involved in regulation of regulatory T cells,28,29 and
deletion of IL-230 or IL-2RA31,32 in mice leads to chronic colitis, hemolytic anemia and
hepatobiliary disease.
Our approach enabled us to reproduce existing arthritis QTLs on chr. 10 and to identify new
ones on chr. 13, 15, and 17. It is likely that more than one genetic factor determines arthritis
susceptibility on chr. 10, as several peaks were observed at closely linked loci and were
either inherited in a recessive or dominant manner depending on phenotype. This is in
concordance with previous linkage analyses that identified mulitple loci contributing to
arthritis susceptibility on this chromosome. QTLs determining susceptibility to collagen-,
oil- and squalene-, pristane-, and mycobacterial adjuvant-induced arthritis have been
identified on chr. 10 using different crosses and/or substitution mapping [reviewed in
Joe21]. The QTL identified in this study is located proximal to Cia5/Cia20 and overlaps
partially or completely with Cia16, Cia21–23, Oia4, Aia5, Pia10, Pia26, and Ciaa2.20–
22,33–36
The chr. 13 linkage to arthritis has not been previously detected in rats. Human homologous
regions map either to chr. 2 [slightly overlapping with OSTEAR1137] or chr. 18, the latter of
which contains RA30.27 An obvious candidate in this region is the Tnfrsf11a (tumor
necrosis factor receptor superfamily, member 11a) gene that is also known as RANK
(receptor activator of Nfkb). Besides regulating T-cell/dendritic cell interaction and lymph
node formation, the RANK/RANK-ligand (L)/osteoprotegrin (OPG) system is a key
regulator of bone remodelling. Its relevance in diseases with altered bone metabolism has
been well investigated, e.g. in osteoporosis, Paget´s disease, and rheumatoid arthritis.38
Excessive expression of RANKL induced by activated T-cells contributes to
osteoclastogenesis and likely contributes to joint destruction in rheumatoid arthritis and
erosive arthritis in the PG-PS arthritis model; moreover, experimental manipulation of the
RANK/RANKL/OPG system prevented bone loss and cartilage destruction in animal
models of arthritis.38–41
The QTL on chr. 15 is located distal to a previously described (unnamed) locus with
suggestive linkage to mycobacterial adjuvant-induced arthritis.21 The peak marker is
located within the glypican (Gpc)5 gene. The human GPC5 gene on chr. 13 has been
implicated to play a role in osteoarthritis development via cartilage degeneration, which was
identified by comparing gene expression in intact versus damaged regions of osteoarthritis
cartilage.42 Furthermore, a polymorphism of the human GPC5 gene is associated to
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symptoms including arthritis following human parvovirus B19 infection.43,44 Glypicans are
cell surface heparan sulfate proteoglycans that are linked with integrin and TGFβ signalling
and play various roles in development and differentiation.45 TGFβ is a key mediator of
regulatory T cell activity.29
Reactive arthritis is a well known extraintestinal manifestation of IBD. As the PG-PS-
induced rat model provides the opportunity to mirror both arthritis and enterocolitis, it
prompted us to investigate if susceptibility to enterocolitis and arthritis is controlled by
common genetic factors or rather independently in this model. Common loci were likely
identified on chr. 17 and chr. 8 (if the suggestive linkage to arthritis of the latter is taken into
account) indicating the involvement of shared mechanisms in susceptibility to both
inflammatory conditions. Candidate genes identified in these regions (Nfrkb and Il2ra) are
in line with this hypothesis. However, with the observation of multiple independent loci, our
study also demonstrates that both conditions are largely regulated by distinct genetic factors.
The linkage on chr. 10 with PG-PS-induced arthritis is in accordance with similar findings in
several other rat models of arthritis, showing that this chromosome contains important
regulators of arthritis susceptibility in the rat. The majority of QTLs associated with arthritis
phenotypes in this study, however, are unique to the PG-PS-induced model. As these QTLs
contain interesting candidate genes (Tnfrsf11a/RANK, Gpc5, Il2ra, Nfrkb) that are also
implicated in human diseases, our model might be of help to elucidate the human situation.
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Lod plot of the arthritis QTL associated with the phenotype “sum of increases in diameter of
both ankles at day 24” on chr. 10. The graphical presentation of the Lod scores determined
by interval mapping demonstrates the complex linkage on chr. 10 with multiple peaks.
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Table 1
Orthogonal factor loadings for the measured phenotypes
Phenotypic trait Factor 1 Factor 2
Gross gut score 0.916 0.131
Liver weight 0.926 0.168
Liver granulomas 0.895 0.155
WBC (103/mm3) 0.849 0.057
Hematocrit (%) −0.791 −0.025
Δ Joint diameter, day 17 (mm)
Left rear ankle 0.035 0.831
Right rear ankle 0.065 0.790
Δ Joint diameter, day 21 (mm)
Left rear ankle 0.117 0.889
Right rear ankle 0.121 0.906
Δ Joint diameter, day 24 (mm)
Left rear ankle 0.132 0.875
Right rear ankle 0.152 0.893
The data from all female F2 mice of this study (n = 168) were subject to factor analysis. The Kaiser-Meyer-Olkin measure is 0.809, indicating a
high sampling adequacy for the factor analysis. Bartlett’s test for sphericity indicates that the factor model is appropriate (p < 0.0005). Factor
loadings > 0.6 are considered to be high and are indicated in bold.
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Table 2
Transformation of phenotype data for QTL analyses
Phenotypic trait Transformation (function)
Gross gut score y=10log[x/(17.00−x)]
Liver weight y=10log[x − 8.05]
Liver granulomas y=10log[(x+0.115)/(4.115−x)]
WBC (103/mm3) y=10log[x − 4.82]
Hematocrit (%) y=10log[x − 19.74]
Δ Joint diameter, day 17 (mm)
Left rear ankle y=1/(x+0.288)
Right rear ankle y=1/(x+0.232)
Δ Joint diameter, day 21 (mm)
Left rear ankle y=1/(x+0.2773)
Right rear ankle y=1/(x+0.2590)
Δ Joint diameter, day 24 (mm)
Left rear ankle y=1/(x+0.2215)
Right rear ankle y=1/(x+0.2111)
Sum of left and right rear ankles y=1/(x+0.3749)
WBC, white blood cell count.
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